WCWenqiang Chen

Wenqiang Chen

*This is an algorithmically generated author record based on publicly available information.

Wenqiang Chen has a total of 140 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Hypochlorous Acid-Responsive Prodrug Nanoplatform for Synergistic Cancer Immunotherapy

    by Xiao Dong, Shu Xia, Xinyu Wang, Cheng Liu, Ran Ji, Mingzhi Wang, Chi Zhang, Liang Chen, Wenqiang Chen, Shao Qin Yao, et al.

    Immunotherapy offers a promising paradigm for cancer treatment, but its efficacy is often constrained by tumor heterogeneity and the immunosuppressive tumor microenvironment. Herein, we constructed a multifunctional nanoplatform (termed MD1a NP) designed to elicit personalized antitumor immunity and overcome tumor immunosuppression by co-assembling a hypochlorous acid (HOCl)-responsive methylene blue (MB)–doxorubicin (DOX) dimer prodrug with a stimulator of interferon genes (STING) agonist (1a). Following intravenous administration, elevated intratumoral HOCl triggers the activation and release of MB and DOX, inducing nanoparticle disassembly and facilitating the liberation of 1a. Upon near-infrared laser irradiation, MB-mediated photodynamic therapy synergizes with DOX-induced chemotherapy to eradicate tumor cells and amplify immunogenic cell death, thereby enhancing the release of tumor antigens and damage-associated molecular patterns. This cascade promotes dendritic cell maturation, which is further reinforced by 1a-mediated STING activation. Moreover, MD1a NP treatment decreases regulatory T-cell populations, alleviates T-cell suppression, and promotes memory T-cell formation. Consequently, MD1a NP combined with laser irradiation remodels the immunosuppressive tumor microenvironment and effectively inhibits both primary and distant tumor growth while preventing lung metastasis in orthotopic 4T1 breast cancer models. This study provides insights into the design of tumor-activatable nanoplatforms for multimodal therapy against immune-desert cancers.

  • Engineering Dual-Mode-Responsive Probes for Real-Time HClO Monitoring in Drug-Induced Liver Injury

    by Wenqiang Chen, Chi Zhang, Jingshuai Wang, Minghui Jiang, Jiarong Sheng, Keyou Li, Xiao Dong, Lei Yang, Siqi Zhang

    Given the critical role of HClO in drug-induced liver injury (DILI), it is essential to establish an accurate and reliable technique for the in situ monitoring of its dynamic changes. Herein, by integrating a phenothiazinecoumarin and a leucomethylene moiety through an aliphatic diamine, a robust dual-mode-responsive HClO probe, PMF3, has been judiciously developed. For the first time, PMF3 can simultaneously respond to HClO through fantastic ratiometric (from 630 to 500 nm) and NIR fluorescence (690 nm) turn-on modes with excellent sensitivity and selectivity, thereby effectively overcoming the limitations of currently reported single-response-mode HClO probes. Encouraged by these impressive sensing properties, PMF3 was successfully used to monitor APAP-induced HClO fluctuations in HepG2 cells via a dual-response mode. Finally, we demonstrated the ability of PMF3 to monitor HClO fluctuations in the liver of DILI mice, and dual-mode fluorescence imaging of DILI model liver tissue sections was also achieved, highlighting its potential value in elucidating pathological mechanisms and facilitating clinical diagnosis of DILI.


  • Hyperbranched Rolling Circle Amplification Enabled Nanopore Sensing Platforms for Ultrasensitive Multiplex MicroRNA Detection and Logic-Gated Molecular Diagnostics

    by Siqi Zhang, Mengkang Zheng, Wei Shi, Kai-Bin Li, Nan You, De-Man Han, Wenqiang Chen

    MicroRNAs (miRNAs) have emerged as crucial biomarker candidates and therapeutic targets for various diseases and cancers, where precise trace-level detection holds significant value for early clinical diagnosis. However, the development of ultrasensitive, isothermal, cost-effective, and reliable miRNA detection platforms remains challenging in clinical applications. Herein, we present a nanopore sensing strategy based on hyperbranched rolling circle amplification (HRCA) for label-free detection and logic-gated diagnosis of miR-122 and miR-141. This method synergistically integrates the high amplification efficiency of HRCA with the single-molecule sensitivity of nanopore sensors, enabling ultrasensitive miRNA detection at ultralow concentrations. The results demonstrate that the HRCA-nanopore system achieves a remarkable detection limit of 0.1 fM, representing a three-order-of-magnitude improvement compared to conventional HRCA-based fluorescence methods, while maintaining excellent specificity to distinguish target miRNAs from interfering sequences. Leveraging the programmable hybridization characteristics and conformational switching of nucleic acids, we further constructed a four-input parallel cascade logic circuit (INHIBIT//INHIBIT-OR) for simultaneous dual-miRNA analysis. This logic architecture establishes a novel conceptual framework for implementing molecular computing in nanopore-based biosensing, particularly for multiplex biomarker diagnosis. The proposed platform not only addresses the critical need for clinical miRNA detection but also provides a versatile paradigm for developing intelligent diagnostic systems through the integration of nucleic acid amplification techniques, nanoscale sensing, and molecular logic operations.


  • Rational Development of a Lipid Droplets and Hypochlorous Acid In-Sequence Responsive Fluorescent Probe for Accurate Imaging of Atherosclerotic Plaques

    by Jingshuai Wang, Shuxing Su, Hongyong Zheng, Chi Zhang, Wenqiang Chen, Siqi Zhang, Qi Xiao, Jiarong Sheng, Lei Yang

    To answer the call for effective and timely intervention in cardiovascular diseases (CVDs), the development of fluorescent probes that can precisely identify atherosclerotic plaques, the root cause of various fatal CVDs, is highly desirable but remains a great challenge. Herein, by integrating bis(trifluoromethyl)benzyl and phenothiazine into the coumarin matrix, a robust fluorescent probe, NOR1, has been developed. NOR1 responds sequentially to lipid droplets (LDs) and HClO via fluorescence turn-on and ratiometric readouts, respectively, with a fast response rate (within 70 s for LDs and 80 s for HClO), excellent sensitivity (detection limit: 0.41 μg/mL for LDs and 23.38 nM for HClO), and high selectivity. Based on these impressive features, NOR1 was successfully applied to discriminate foam cells from others by simultaneously monitoring two hallmark events, lipid accumulation and oxidative stress, in foam cells. Furthermore, the use of NOR1 to monitor in real time the transformation process of A7r5 cells into foam cells under high LDL/glucose conditions was successfully realized for the first time. Importantly, we further demonstrate the ability of NOR1 to precisely identify atherosclerotic plaques with clear margin delineation, highlighting its potential utility in elucidating the pathological mechanism and clinical diagnosis of atherosclerosis.


  • Merging 2,3-butanedione and N-hydroxysuccinimide as visible-light-enabled hydrogen atom transfer catalysts for CC double bond cleavage of 2-cyanoaryl acrylamides toward the synthesis of 4-amino-2-quinolones

    by Jun Huang, Fengting Zhu, Jinlian Wen, Jiali Xu, Jing-Mei Yuan, Wenqiang Chen

    The CC double bond cleavage of 2-cyanoaryl acrylamides through merging 2,3-butanedione and N-hydroxysuccinimide as visible-light-enabled hydrogen atom transfer catalysts is effectively established.


  • De Novo Design of a Highly Stable Ratiometric Probe for Long-Term Continuous Imaging of Endogenous HClO Burst

    by Wenqiang Chen, Wenju Xu, Jiayi Xing, Qixuan Liu, Jinshuai Wang, Meijun Meng, Jiarong Sheng, Qi Xiao, Lintao Zeng, Lei Yang

    Long-term continuous imaging of endogenous HClO burst is of great importance for the elucidation of various physiological or pathological processes. However, most of the currently reported HClO probes have failed to achieve this goal due to their insufficient photobleaching resistance under a laser source. Herein, a highly stable ratiometric probe, HFTC-HClO 1, which is capable of continuously monitoring endogenous HClO burst over a long period of time, has been judiciously developed. Briefly, the de novo development of HFTC-HClO 1 mainly involved three main steps: (1) novel coumarins (HFTC 1-5) were designed and synthesized; (2) the most stable scaffold, HFTC 3, was selected through dye screening and cell imaging validation; and (3) based on HFTC 3, three candidate HClO probes were constructed, and HFTC-HClO 1 was finally selected due to its superior sensing properties toward HClO. Furthermore, HFTC-HClO 1 can quantitatively measure HClO levels in various real samples with excellent recovery (>90.4%), and the use of HFTC-HClO 1-coated test strips for qualitative analysis of HClO in real samples was also achieved. In addition, the application of HFTC-HClO 1 for long-term continuous monitoring of intracellular HClO burst was successfully demonstrated. Significantly, HFTC-HClO 1 was able to visualize HClO generated in the rheumatoid arthritis mouse model.


  • Homoadamantane-Fused Tetrahydroquinoxaline as a Robust Electron-Donating Unit for High-Performance Asymmetric NIR Rhodamine Development

    by Zhipeng Chen, Lei Yang, Wenju Xu, Feifei Xu, Jiarong Sheng, Qi Xiao, Xiangzhi Song, Wenqiang Chen

    Rhodamines have emerged as a useful class of dye for bioimaging. However, intrinsic issues such as short emission wavelengths and small Stokes shifts limit their widespread applications in living systems. By taking advantage of the homoadamantane-fused tetrahydroquinoxaline (HFT) moiety as an electron donor, we developed a new class of asymmetric NIR rhodamine dyes, NNR1-7. These new dyes retained ideal photophysical properties from the classical rhodamine scaffold and showed large Stokes shifts (>80 nm) with improved chemo/photostability. We found that NNR1-7 specifically target cellular mitochondria with superior photobleaching resistance and improved tolerance for cell fixation compared to commercial mitochondria trackers. Based on NNR4, a novel NIR pH sensor (NNR4M) was also constructed and successfully applied for real-time monitoring of variations in lysosomal pH. We envision this design strategy would find broad applications in the development of highly stable NIR dyes with a large Stokes shift.


  • De Novo Design of a Robust Fluorescent Probe for Basal HClO Imaging in a Mouse Parkinson’s Disease Model

    by Jiali Chen, Yao Lu, Yue Wu, Zhipeng Chen, Xingjiang Liu, Chengwu Zhang, Jiarong Sheng, Lin Li, Wenqiang Chen, Xiangzhi Song

    Elevated HClO gets involved in the pathogenesis of Parkinson’s disease (PD). Herein, a novel fluorescent probe NUU-1 was designed and synthesized. Distinct from the general strategies, NUU-1 features two distinct HClO reactive sites, a HClO-specific reaction site and a HClO-nonspecific reactive site, which in turn endows NUU-1 with the “0 + 1 > 1” amplification effect, that thus dramatically promotes the selectivity. NUU-1 displayed a fast response rate (within 15 s), remarkable fluorescence enhancement (about 538-fold), and excellent sensitivity (LOD = 25.8 nM) in response to HClO while the remaining fluorescence silence toward other common ROS (H2O2, •OH, ONOO–, O2•–, and 1O2) even at high concentrations (up to 0.5 mM). NUU-1 allows for the imaging of both exogenous and endogenous HClO in living dopaminergic cells (SH-SY5Y). Moreover, by employing NUU-1 as the probe, the image of HClO in C. elegans and zebrafish was successfully achieved. Significantly, in the first trial, NUU-1 was successfully utilized for the brain basal HClO imaging in PD mice models and distinguished PD brain tissues from normal control, thereby holding great potential for in-depth biological applications.


  • Broad-Spectrum Polymeric Nanoquencher as an Efficient Fluorescence Sensing Platform for Biomolecular Detection

    by Xiao Dong, Sing Yee Ong, Changyu Zhang, Wenqiang Chen, Shubo Du, Qicai Xiao, Liqian Gao, Shao Q. Yao

    Colloidal inorganic nanostructures (metal, carbon, and silica) have been widely used as “nanoquenchers” for construction of nanosensors; however, inherent drawbacks such as insufficient fluorescence quenching efficiency, false positive signals, and uncertain long-term cytotoxicity have limited their further utility. Herein, by taking advantages of polymeric nanoparticles (PNPs) in terms of high loading capacity, facile surface modification chemistry, and good biocompatibility, we report a broad-spectrum (400–750 nm) polymeric fluorescence-quenching platform for sensor fabrication. Our newly developed polymeric nanoquenchers (qPNPs) were constructed by concurrently encapsulating various alkylated black-hole quenchers into nanoparticles made of poly(methyl methacrylate-co-methacrylic acid) and were found to have an excellent fluorescence quenching effect (>400-fold) on common fluorophores (FAM, TMR, and Cy5) together with high stability under physiological conditions. As a proof of concept, the feasibility of these qPNPs for fluorescence sensing was validated by successful construction of two nanosensors (FAM[email protected]qPNP and Cy5[email protected]qPNP), which could be used as promising nanosensors for live-cell imaging of the apoptosis-related protease caspase-3 and cancer-related survivin mRNA, respectively. As expected, in the FAM channel, the FAM[email protected]qPNP showed fast and selective fluorescence responses toward caspase-3 in buffers and could be used to image the activation of drug-induced endogenous caspase-3. In the Cy5 channel, the Cy5[email protected]qPNP could be used to distinguish normal cells (MCF10A) from cancer cells (HeLa) by quantitatively detecting the endogenous survivin mRNA level. It could be further used to monitor changes in the endogenous survivin mRNA expression levels in drug-treated HeLa cells. Altogether, by virtue of their high quencher loading and broad-spectrum quenching efficiency and good signal-to-background ratio, these qPNPs might be particularly attractive alternatives to other conventional nanoquenchers for the construction of more complex biosensors in the future.